The highest mortality rate associated with acute coronary syndrome is observed in patients with ST-segment elevation myocardial infarction (STEMI). Quality care in STEMI management depends on timely reperfusion of the…
Chronic kidney disease (CKD) increases the risk of death and other poor outcomes in patients with cardiovascular diseases. This study investigated the relation between the institutional CKD percutaneous coronary intervention…
Very few studies evaluated the impact of acute kidney injury (AKI) and chronic kidney disease (CKD) on heart failure (HF) hospitalization risk following an acute myocardial infarction (AMI ). For…
Hypertension and type 2 diabetes mellitus (T2DM) are common co-morbidities, with hypertension being twice as frequent in patients with T2DM as in those without. , Blood pressure (BP) control is…
We read with interest the communication by Dr. Amit Alam, “Effect of Near Monopoly in the Left Ventricular Assist Device Market.” Dr. Alam makes a convincing argument for the need…
The optimal duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) is still debated. Current American and European guidelines recommend at least 6 months of DAPT after drug-eluting…
Statins have strong recommendations for secondary prevention of future cardiovascular events in patients with ischemic heart disease (IHD). However, statins remain vastly underused in patients with cardiovascular disease and those…
Most medications are not labeled for use in the pediatric population because they have not been formally studied in children. Data on off-label use of cardiovascular (CV) drugs in the…
Significant effort has been put into the optimization of the antenatal diagnosis of coarctation of the aorta (CoA). However, although left-sided cardiac lesions are known to cluster, the necessity to…
Regarding the drug interactions between sacubitril/valsartan and statins, we identified 3 reports of rhabdomyolysis with high-potency statins. However, it remains unknown whether the combined use of these medications could lead…
